“Picolog,” a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo

por DeChristopher, Brian A., Fan, Alice C., Felsher, Dean W., Wender, Paul A.
Publicado 2012

Designed, Synthetically Accessible Bryostatin Analogues Potently Induce Activation of Latent HIV Reservoirs in vitro

por DeChristopher, Brian A., Loy, Brian A., Marsden, Matthew D., Schrier, Adam J., Zack, Jerome A., Wender, Paul A.
Publicado 2012

Pharmacological Inhibition of MALT1 Ameliorates Autoimmune Pathogenesis and Can Be Uncoupled From Effects on Regulatory T-Cells

por Biswas, Subhabrata, Chalishazar, Aditi, Helou, Ynes, DiSpirito, Joanna, DeChristopher, Brian, Chatterjee, Devin, Merselis, Leidy, Vincent, Benjamin, Monroe, John G., Rabah, Dania, Long, Andrew J.
Publicado 2022

Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death

por Staveness, Daryl, Abdelnabi, Rana, Schrier, Adam J., Loy, Brian A., Verma, Vishal A., DeChristopher, Brian A., Near, Katherine E., Neyts, Johan, Delang, Leen, Leyssen, Pieter, Wender, Paul A.
Publicado 2016

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents

por Marsden, Matthew D., Wu, Xiaomeng, Navab, Sara M., Loy, Brian A., Schrier, Adam J., DeChristopher, Brian A., Shimizu, Akira J., Hardman, Clayton T., Ho, Stephen, Ramirez, Christina M., Wender, Paul A., Zack, Jerome A.
Publicado 2018